Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern Cooperative Oncology Group Study

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern cooperative oncology group study

Medical and Pediatric Oncology ◽

10.1002/mpo.2950170306 ◽

1989 ◽

Vol 17 (3) ◽

pp. 197-201 ◽

Cited By ~ 10

Author(s):

David S. Ettinger ◽

Dianne M. Finkelstein ◽

Ross C. Donehower ◽

Alex Y. C. Chang ◽

Michael Green ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

10.1097/01243894-200609000-00012 ◽

2006 ◽

Vol 1 (7) ◽

pp. 673-678 ◽

Cited By ~ 3

Author(s):

Gregory A. Masters ◽

Sigui Li ◽

Afshin Dowlati ◽

Stefan Madajewicz ◽

Corey Langer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/85.5.388 ◽

1993 ◽

Vol 85 (5) ◽

pp. 388-394 ◽

Cited By ~ 233

Author(s):

A. Y. Chang ◽

K. Kim ◽

J. Glick ◽

T. Anderson ◽

D. Karp ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iv ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung

A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

10.1016/s1556-0864(15)30380-4 ◽

2006 ◽

Vol 1 (7) ◽

pp. 673-678

Author(s):

Gregory A. Masters ◽

Sigui Li ◽

Afshin Dowlati ◽

Stefan Madajewicz ◽

Corey Langer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

British Journal of Cancer ◽

10.1038/sj.bjc.6601462 ◽

2004 ◽

Vol 90 (1) ◽

pp. 87-92 ◽

Cited By ~ 30

Author(s):

N Yamamoto ◽

◽

M Fukuoka ◽

S-I Negoro ◽

K Nakagawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer: An Eastern Cooperative Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(95)96460-d ◽

1995 ◽

Vol 12 (1-2) ◽

pp. 155

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern Cooperative Oncology Group

10.1097/jto.0b013e31819c7daf ◽

2009 ◽

Vol 4 (4) ◽

pp. 527-533 ◽

Cited By ~ 10

Author(s):

Leora Horn ◽

Patricia Bernardo ◽

Alan Sandler ◽

Henry Wagner ◽

Nathan Levitan ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung

Phase II Study of Sequential Triplet Chemotherapy, Irinotecan and Cisplatin Followed by Amrubicin, in Patients with Extensive-Stage Small Cell Lung Cancer: West Japan Thoracic Oncology Group Study 0301

10.1097/jto.0b013e3181dd1591 ◽

2010 ◽

Vol 5 (7) ◽

pp. 1075-1080 ◽

Cited By ~ 6

Author(s):

Masashi Kobayashi ◽

Kaoru Matsui ◽

Yasuo Iwamoto ◽

Noriyuki Ebi ◽

Satoshi Oizumi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study ◽

Extensive Stage

Randomized phase II study of docetaxel plus cisplatin versus docetaxel plus irinotecan in advanced non-small-cell lung cancer. A West Japan Thoracic Oncology Group Study

Lung Cancer ◽

10.1016/s0169-5002(00)80070-7 ◽

2000 ◽

Vol 29 (1) ◽

pp. 23

Author(s):

H Saito ◽

N Yamamoto ◽

S Negoro ◽

K Nakagawa ◽

K Matsui ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study ◽

Randomized Phase Ii

P-774 Phase II study of cisplatin plus etoposide with concurrent thoracic radiotherapy (TRT) followed by innotecan plus cisplatin in limited stage small-cell lung cancer (SCLC); A West Japan Thoracic Oncology Group Trial

Lung Cancer ◽

10.1016/s0169-5002(05)81267-x ◽

2005 ◽

Vol 49 ◽

pp. S322 ◽

Cited By ~ 1

Author(s):

T. Kashii ◽

H. Saito ◽

S. Negoro ◽

Y. Takada ◽

Y. Ichinose ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Group Trial